Abstract:Organophosphate esters (OPEs) can exhibit various toxicities including endocrine disruption activity. Unfortunately, the low-dose endocrine-disrupting effects mediated by estrogen receptors (ERs) are commonly underestimated for OPEs and their metabolites. Here, structure-oriented research was performed to investigate the estrogenic/antiestrogenic effect of 13 OPEs (including three metabolites) and the potential mechanism. All of the OPEs exerted antiestrogenic activities in both E-screen and MVLN assays. OPEs with bulky substituents, such as phenyl rings (triphenyl phosphate (TPP), tricresyl phosphate (TCP), diphenylphosphoryl chloride, and diphenylphosphite) or relatively long alkyl chains (dibutylbutylphosphonate (DBBP)), exerted relatively strong ER antagonism potency at micromolar concentrations. The established quantitative structure–activity relationship indicated that the antiestrogenic activities of the OPEs mainly depended on the volume, leading eigenvalue, and hydrophobicity of the molecule. Molecular docking revealed that the three OPEs with the bulkiest substituents on the phosphate ester group (TPP, TCP, and DBBP) have a similar interaction mode to the classical ER antagonist 4-hydroxytamoxifen. The correlation between the antiestrogenic activity and the corresponding ER binding affinity was statistically significant, strongly suggesting that the OPEs possess the classical antagonism mechanism of interfering with the positioning of helix 12 in the ER.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.est.0c04376?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.est.0c04376</a>.Docking scores, molecular parameters, and activity data of OPEs (Table S1); RNA isolation and reverse transcription polymerase chain reaction (RT-PCR) (Part 1); the process of QSAR development and the robustness of the QSAR model (Part 2); antiproliferation effect of each OPE in the E-screen assay under single exposure scenario (Figure S1); antiluciferase activities of OPEs after cotreatment with E2 in the MVLN assay (Figure S2); empirical distribution of R2* for the PEC50 model in the antiproliferation activity of OPEs (cotreatment with E2) in the E-screen assay (Figure S3); empirical distribution of R2* for the PEC50 model in the antiluciferase activity of OPEs (exposure alone) in the MVLN assay (Figure S4); empirical distribution of R2* for the PEC50 model in the antiluciferase activity of OPEs (cotreatment with E2) in the MVLN assay (Figure S5); and the binding modes of five OPE molecules in hERα-LBD (Figure S6) (<a class="ext-link" href="/doi/suppl/10.1021/acs.est.0c04376/suppl_file/es0c04376_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Detection of Estrogenic Effects of Organophosphorus Pesticides on MCF-7 Human Breast Cancer Cells

Effect of N-3 and N-6 Polyunsaturated Fatty Acids on Lipid Metabolic Genes and Estrogen Receptor Expression in MCF-7 Breast Cancer Cells.

Evaluation of toxicological effects of organophosphorus pesticide metabolites on human HepG2 cells

The risk and impact of organophosphate esters on the development of female-specific cancers: Comparative analysis of patients with benign and malignant tumors

Endocrine Disrupting Effects of Dichlorodiphenyltrichloroethane Analogues on Gonadotropin Hormones in Pituitary Gonadotrope Cells

[Assessment of the Estrogenicity of Endosulfan and Other Chemicals with the in Vitro Proliferation of Human Breast Cancer Cell]

Human drug metabolism genes in parathion-and estrogen-treated breast cells

The Potential Endocrine Disruption of Pesticide Transformation Products (tps): the Blind Spot of Pesticide Risk Assessment.

Assessment of Five Pesticides as Endocrine-Disrupting Chemicals: Effects on Estrogen Receptors and Aromatase

Assessment of Endocrine-Disrupting Effects of Emerging Polyhalogenated Carbazoles (phczs): in Vitro, in Silico, and in Vivo Evidence

Screening of potential oestrogen receptor α agonists in pesticides via in silico, in vitro and in vivo methods

Concentration-dependent effects of chlorpyrifos oxon on peroxisome proliferator-activated receptor signaling in MCF-7 cells

Exposure Assessment of Aryl-Organophosphate Esters Based on Specific Urinary Biomarkers and Their Associations with Reproductive Hormone Homeostasis Disruption in Women of Childbearing Age.

Structure-Oriented Research on the Antiestrogenic Effect of Organophosphate Esters and the Potential Mechanism

Comparative in vitro and in silico study on the estrogenic effects of 2,2-bis(4-chlorophenyl)ethanol, 4,4′-dichlorobenzophenone and DDT analogs

Estrogenic Activity of Lambda-Cyhalothrin in the Mcf-7 Human Breast Carcinoma Cell Line

Effects of Polychlorinated Biphenyl(Pcb101) and Its Hydroxylated Metabolites on Proliferation of Mcf-7 Human Breast Cancer Cells

GPR39-mediated ERK1/2 signaling reduces permethrin-induced proliferation of estrogen receptor α-negative cells

Assessment of the endocrine-disrupting effects of diethyl phosphate, a nonspecific metabolite of organophosphorus pesticides, by in vivo and in silico approaches

Electrochemistry detection of estrogenic effect: Regulation of de novo purine synthesis and catabolism by gibberellin and fulvestrant

Effects of long-term exposure to low levels of organophosphorous pesticides and their mixture on altered antioxidative defense mechanisms and lipid peroxidation in rat liver